On December 29, Guangzhou Improve Medical Instruments Co.Ltd(300030) (300030. SZ) issued two announcements related to data changes. According to the announcement, the company has completed the industrial and commercial change procedures of its registered address, registered capital and company name on December 28, moved its registered place from Guangzhou to Zhuhai Hengqin New Area (Hengqin pilot Free Trade Zone), and the company name has been changed from ” Guangzhou Improve Medical Instruments Co.Ltd(300030) ” to ” Guangzhou Improve Medical Instruments Co.Ltd(300030) Technology Co., Ltd.”. Meanwhile, Guangzhou Improve Medical Instruments Co.Ltd(300030) newly established a wholly-owned subsidiary Guangzhou Guangzhou Improve Medical Instruments Co.Ltd(300030) Instrument Co., Ltd. (“Yangpu instrument”) at the original registered address to take over the plant certified by the competent department GPM and ensure that the normal production and operation will not be affected.
The renaming and relocation mainly stems from the strategic cooperative relationship established between the company and Zhuhai Hengqin New Area in June this year. According to the contents of the previous strategic cooperation agreement, the company promises to move its registered place to Hengqin new area, and the incremental business and production capacity will be gradually transferred to Hengqin, so as to build a medical industry cluster with precision medicine and intelligent medicine as the core. The partner Zhuhai Hengqin New Area Management Committee provides the company with land for office, R & D, production capacity and other projects, and supports corresponding industrial policies, subsidies, incentives and other incentives.
In addition, on June 23, 2021, Deng Guanhua reached an equity transfer agreement with Zhuhai Gree Financial Investment Management Co., Ltd. (Gree capital investment). On December 6, the corresponding equity and voting rights were changed, and the shareholding proportion of Gree capital investment increased to 10.86%, becoming the shareholder with the largest proportion of voting rights of the company’s shares. The actual controller of the company was changed from Deng Guanhua to Zhuhai SASAC.
Statistics show that Gree capital investment is the leading state-owned enterprise and the first state-owned capital investment and operation platform in Zhuhai. Since its establishment in 2017, it has focused on investment in the five industrial clusters of integrated circuits, biomedicine, new materials, new energy and high-end printing equipment in Zhuhai. The invested projects include Changyuan Technology Group Ltd(600525) , Zhuhai Orbita Aerospace Science & Technology Co.Ltd(300053) , Shenzhen Comix Group Co.Ltd(002301) , Zhuhai Enpower Electric Co.Ltd(300681) and other high-quality enterprises, And successfully promoted more than 30 industrial projects to land in Zhuhai by “promoting investment and introduction”.
The company said that the ownership of state-owned assets not only optimizes the ownership structure of the company and realizes the resource integration of state-owned assets and private assets, but also further enhances the overall anti risk ability of the company and promotes the orderly and healthy development of all businesses of the company.
It is reported that Zhuhai attaches great importance to the development of emerging fields such as biomedicine and high-end manufacturing. The relocation of Guangzhou Improve Medical Instruments Co.Ltd(300030) as the leader of China’s vacuum blood collection system to Zhuhai Hengqin new area will help the company fully enjoy the support given by Hengqin free trade zone and Zhuhai industrial policies, help the company continue to develop in new business areas, complete the creation of a new growth curve in the field of in vitro diagnosis (IVD), and achieve sustainable growth of performance.
In addition, according to the announcement, the board of directors of the company reviewed matters related to the first vesting period of the 2020 stock incentive plan on November 22, and completed the change of the corresponding registered capital on December 28. The company attributed 391500 restricted shares to 17 incentive objects who met the vesting conditions, and the registered capital of the company was changed from 308795800 yuan to 309187300 yuan.
(Securities Times)
